Clinical Trials Directory

A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients

Impact of the Korea Early Childhood Home-visiting Intervention

A Study of NKT2152, a HIF2α Inhibitor, in Patients with Advanced Clear Cell Renal Cell Carcinoma

PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

Medication Use and Quality of Life Among Older People

A Health Action Process Approach Online Intervention for People With Multiple Sclerosis

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

Obstructive Sleep Apnea and Comprehensive Remotely-supervised Rehabilitation Program

Enhancing Cancer Care Of Rural Dwellers

Adjunct Targeted Temperature Management in Acute Severe Carbon Monoxide Poisoning

Socioeconomic Inequalities in the Diagnosis and Treatment of Colon and Ovarian Cancer in England Between 2016-2017

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

Harmony TPV Post-Approval Study

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

Missed Period Pill Study

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan

Safety and Efficacy of MEE-HU Medicus

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Home Food Delivery for Diabetes Management in Patients of Rural Clinics

A Study of FDA018-ADC in Patients with Advanced Solid Tumors

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Treatment of Occult Inguinal Hernias

Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients with GEP-NET

ACUPUNCTURE FOR THE POSTOPERATIVE RECOVERY OF HIP FRACTURE PATIENTS: A PILOT RANDOMIZED CONTROLLED TRIAL

Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients

Osteosarcoma Maintenance Therapy With OST31-164

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

Rebreathing-induced Hypoxia and Glucose Levels

Enhancing Mental and Physical Health of Women Veterans

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer

CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab

PENG vs. FIC Block for Hip Fracture ED Patients

Study of Acalabrutinib and Tafasitamab in MZL Patients

Post Market Clinical Follow-Up Study in Patients Treated With the On-X Ascending Aortic Prosthesis (AAP)

Renal and Urinary Manifestations of Chronic Inflammatory Bowel Diseases.

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Late Anthracycline Induced Cardiotoxicity- Childhood Cancer Survivors

Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors

Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM

CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)

A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma

Intervention-Induced Plasticity of Flexibility and Learning Mechanisms in ASD